Journal: Oncotarget
Article Title: Hyperactivated mTORC1 downregulation of FOXO3a/PDGFRα/AKT cascade restrains tuberous sclerosis complex-associated tumor development
doi: 10.18632/oncotarget.18963
Figure Lengend Snippet: ( A , B ) Tsc2−/− (A) or Tsc1−/− MEFs (B) were infected with lentivirus harboring a vector encoding PDGFRɑ (LV-PDGFRɑ) or the empty vector (LV). ( C ) Tsc2+/+ MEFs stably expressing shRNAs targeting PDGFRɑ (shPDGFRɑ) or a control shRNA (shSc). A–C. Cell lysates were subjected to immunoblotting with the indicated antibodies. ( D ) Proliferation of the indicated cells was examined using an MTT assay. ( E ) The colonies formed by the indicated cells were stained and counted. Representative images (left panels) and quantifications (right panels). ( F , G ) Tsc2−/− (F) or Tsc1−/− MEFs (G) transduced with LV-PDGFRɑ or LV lentiviruses were inoculated subcutaneously into nude mice, followed by monitoring for tumor growth. ( H , I ) Tumor tissues derived from Tsc2−/− (H) or Tsc1−/− MEFs (I) were fixed and embedded with paraffin, and then subjected to H&E and immunohistochemical staining. Representative images were presented. Scale bar, 50 μm. ** P < 0.01; *** P < 0.001.
Article Snippet: GV248 lentiviral shRNA expression vectors targeting mouse PDGFRɑ, mouse Raptor, mouse Rictor, and the control scrambled shRNA (shSc) were obtained from Genechem (Shanghai, China).
Techniques: Infection, Plasmid Preparation, Stable Transfection, Expressing, Control, shRNA, Western Blot, MTT Assay, Staining, Transduction, Derivative Assay, Immunohistochemical staining